Methods and compositions for unsilencing imprinted genes
US9714427B2 · kind B2 · utility
2Cited by
0References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 9, 2011 |
| Grant date | Jul 25, 2017 |
| Priority date | — |
| Expiry date | May 8, 2033 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/713
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods and compositions for inducing expression of Ube3a in a cell by contacting the cell with a topoisomerase inhibitor. Particular embodiments include a method of treating a genomic imprinting disorder, such as Angelman syndrome, in a subject by administering to the subject an effective amount of a topoisomerase inhibitor.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.